Excessive Growth of Eyelashes in a Patient with AIDS Being Treated with Zidovudine

To the Editor: Hypertrichosis of the eyelashes associated with zidovudine therapy in the treatment of patients with the acquired immunodeficiency syndrome (AIDS) has not to our knowledge been reported as a drug-induced adverse effect. We present a case of hypertrichosis of the eyelashes that occurred two weeks after the patient started zidovudine therapy. A 30-year-old man returned to our clinic on March 29, 1990, approximately two weeks after the initiation of zidovudine therapy at a dose of 200 mg every four hours. The zidovudine had been started after he was found to have an absolute number of CD4 lymphocytes of . . .